Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

BACKGROUND: Women with SLE have higher rates of persistent human papilloma virus (HPV) infections and precancerous lesions than healthy women. HPV vaccine is safe and effective in healthy females aged 9–26 years. There are limited data on the safety and immunogenicity of HPV vaccine in females with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Soybilgic, Arzu, Onel, Karen B, Utset, Tammy, Alexander, Kenneth, Wagner-Weiner, Linda
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751269/
https://ncbi.nlm.nih.gov/pubmed/23924237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-11-29
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki